2019-11-14T12:42:26-06:00 2018-12-31 814234542 BPM LLP 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 940251021 990 2018-01-01 264443340 MEDICINES360 MEDI 4159518700 353 SACRAMENTO STREET SUITE 300 SAN FRANCISCO CA 94111 BRADLEY LUKE CFO 4159518700 2019-11-09 1 CAROLYN R AMSTER P00189994 6508556800 2019-11-09 208.184.139.130 2019-11-09 10:46:34 PS P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 155DBB0B033CCB00695FD1C9AE35DD64086CB893 2018 2020-03-31 21:24:44Z JESSICA GROSSMAN 353 SACRAMENTO STREET SUITE 300 SAN FRANCISCO CA 94111 44444919 0 X HTTP://WWW.MEDICINES360.ORG X 2009 CA MEDICINES360 IS A NON-PROFIT PHARMACEUTICAL COMPANY THAT ADDRESSES THE UNMET NEEDS OF WOMEN BY DEVELOPING INNOVATIVE, AFFORDABLE AND SUSTAINABLE MEDICAL SOLUTIONS. 6 5 43 0 0 19278 7323782 600400 10290698 8790698 2033388 2366427 3678183 4926736 23326051 16684261 50000 25000 0 0 6877489 7806787 0 0 174154 10106750 13524205 17034239 21355992 6291812 -4671731 98482629 87075006 29917281 28112017 68565348 58962989 MEDICINES360 IS A NON-PROFIT PHARMACEUTICAL COMPANY THAT ADDRESSES UNMET NEEDS OF WOMEN BY DEVELOPING INNOVATIVE, AFFORDABLE AND SUSTAINABLE MEDICAL SOLUTIONS. 0 0 17140267 25000 8790698 THE ORGANIZATION RECEIVED NDA APPROVAL FOR ITS IUD PRODUCT LILETTA IN 2015. LILETTA HAS BEEN DISTRIBUTED THROUGH MEDICINES360'S COMMERCIAL PARTNER SINCE APRIL 2015. THE ORGANIZATION HAS CONTINUED CLINICAL TRIALS BEYOND THE INITIAL APPROVAL FOR THE PRODUCT. IN ADDITION, THE ORGANIZATION CONTINUES DEVELOPING CERTAIN MEDICAL PRODUCTS RELATING TO WOMEN'S REPRODUCTIVE HEALTH AND WORKS TO EXPAND ACCESS TO ALL WOMEN IN NEED. 17140267 1 1 0 1 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 1 59 0 1 43 1 0 0 0 0 0 0 0 0 0 0 0 0 X 6 5 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X BRADLEY LUKE 4159518700 353 SACRAMENTO STREET SUITE 300 SAN FRANCISCO CA 94111 JESSICA GROSSMAN DIRECTOR/CEO 40.00 0.00 X X 694329 0 276011 LESLIE BENET DIRECTOR, CHAIR 2.00 0.00 X 60000 0 0 LISA DAVID DIRECTOR 2.00 2.00 X 40000 40000 0 KAREN DAWES DIRECTOR 2.00 0.00 X 40000 0 0 ANN BARBER DIRECTOR 2.00 0.00 X 40000 0 0 MICHAEL DORSEY DIRECTOR 2.00 0.00 X 40000 0 0 BRADLEY LUKE CHIEF FINANCE OFFICER 35.00 5.00 X 340826 53011 119056 ETHAN KNOWLDEN SENIOR CORPORATE COUNSEL/BOD SECRETARY 35.00 5.00 X 237393 36923 108270 ANDREA OLARIU CHIEF OPERATING OFFICER 28.00 12.00 X 357859 150247 210738 SALLY STEPHENS CHIEF BUSINESS OFFICER 39.50 0.50 X 427320 4185 124837 MARK BUSCH VP, QUALITY ASSURANCE 12.50 27.50 X 239575 107234 100344 ROBERT STARR EXECUTIVE DIRECTOR, CLINICAL OPS & MEDICAL AFFAIRS 26.50 13.50 X 191350 96827 82104 ROBERT DECKMAN VP, PRODUCT DEVELOPMENT 38.50 1.50 X 276342 10082 123244 SUSAN MARTIN VP, US COMMERCIAL BUSINESS 40.00 0.00 X 284220 0 96318 AUTUMN EHNOW VP, PUBLIC POLICY & GOVERNMENT AFFAIRS 40.00 0.00 X 247230 0 89232 3516444 498509 1330154 24 0 1 0 JPA HEALTH COMMUNICATIONS 1101 CONNECTICUT AVENUE NW STE 600 WASHINGTON DC 20036 CONSULTANT SERVICES 675250 SYNTERACT INC 5909 SEA OTTER PLACE STE 100 CARLSBAD CA 92010 CONSULTANT SERVICES 634229 CAMBER COLLECTIVE LLC 408 N 35TH STREET STE A SEATTLE WA 98103 CONSULTANT SERVICES 548462 KCAS LLC 12400 SHAWNEE MISSION PARKWAY SHAWNEE KS 66216 CONSULTANT SERVICES 346471 UNIVERSITY OF CALIFORNIA DAVIS 2468 HIGH STREET PALO ALTO CA 94301 CONSULTANT SERVICES 271387 11 600400 600400 RESEARCH AND DEVELOPMENT 541700 6000000 6000000 LICENSE AGREEMENT 900099 2790698 2790698 8790698 2207213 2207213 4926736 4926736 27919872 27760658 159214 159214 159214 16684261 8790698 0 7293163 X 25000 25000 2533609 1320405 1130042 83162 4255353 3518924 711701 24728 154329 116276 36161 1892 534777 393347 134794 6636 328719 235128 88474 5117 361418 140490 220928 77502 77502 335317 335317 7492031 6946941 535072 10018 2044636 2027739 16897 470323 334426 128618 7279 492585 352339 132578 7668 944374 716962 214977 12435 244987 175236 65937 3814 546325 390778 147042 8505 TAXES 4258 4258 FDA FEES 305600 305600 EMPLOYEE EVENTS 62736 44874 16885 977 PAYROLL PROCESSING 47551 34013 12798 740 94562 61789 31590 1183 21355992 17140267 4041571 174154 596001 1790885 5256047 2354010 3996823 2047503 2184427 1619060 1137957 1474567 2243424 1637721 880540 605703 78184791 70597370 6153748 6493613 92295 92295 98482629 87075006 2707978 3693412 27209303 24418605 29917281 28112017 X 67250867 58462049 1314481 500940 68565348 58962989 98482629 87075006 X -4671731 -4309903 -620725 X 0 1 X 1 0 X UNIVERSITY OF CALIFORNIA DAVIS CA RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 0 1 9159 0 1 34856 0 0 44015 0 PART II-B, LINE 1: MEDICINES360'S POLICY POSITIONS HAVE BEEN ROOTED IN EVIDENCE WITH A FOCUS ON PROVIDING A CORPORATE RESPONSE TO PROTECT AND CONVEY OUR MISSION AS A NON-PROFIT PHARMACEUTICAL COMPANY FOCUSED ON WOMEN'S HEALTH. WE HAVE ACTIVELY ENGAGED WITH FEDERAL AND STATE POLICY MAKERS TO CONVEY OUR POSITION ON 340B POLICIES, TITLE X AND LARC RELATED AND DRAFT LEGISLATION. WE HAVE ALSO ISSUED MEDIA STATEMENTS ON OUR PRIORITY ISSUES AND PUBLIC COMMENT TO THE RECORD FOR SENATE AND HOUSE HEARINGS ON THESE TOPICS. 808921 348396 460525 1434503 1289325 145178 605703 INVESTMENT - SUB 1000 F ALTERNATIVE INVESTMENTS 6492613 F 6493613 CENTRAL AMERICA AND THE CARIBBEAN - ANTIGUA & BARBUDA, ARUBA, BAHAMAS, 0 0 INVESTMENTS 6492613 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES MARKET RESEARCH 5000 0 0 0 0 0 0 6497613 0 6497613 1 0 1 1 0 0 1 ESSENTIAL ACCESS HEALTH 3600 WILSHIRE BLVD STE 600 LOS ANGELES CA 94549 952564024 501(C)(3) 15000 GENERAL SUPPORT 1 0 PART I, LINE 2: THE ORGANIZATION HAS A VERY RIGOROUS AND CONTROLLED PROCESS, INCLUDING MULTIPLE REVIEWS AND APPROVALS, FOR SELECTING RECIPIENTS OF CONTRIBUTIONS (PUBLIC CHARITIES). GRANT PERIODS ARE VERY SHORT IN DURATION AND USE OF FUNDS MUST ALIGN WITH THE MISSION OF MEDICINES360. GIVEN THESE STRINGENT SELECTION CRITERIA, POSTAWARD OVERSIGHT AND REPORTING IS NOT REQUIRED. X 0 1 X X X X X 0 0 0 0 0 0 0 1 0 JESSICA GROSSMAN DIRECTOR/CEO 491689 0 200880 0 1760 0 240050 0 35961 0 970340 0 200880 0 BRADLEY LUKE CHIEF FINANCE OFFICER 256110 39834 82404 12817 2312 360 93649 14566 9382 1459 443857 69036 82404 12817 ETHAN KNOWLDEN SENIOR CORPORATE COUNSEL/BOD SECRETA 235463 36623 0 0 1930 300 75712 11776 17985 2797 331090 51496 0 0 ANDREA OLARIU CHIEF OPERATING OFFICER 268867 112884 87752 36843 1240 520 111474 46802 36949 15513 506282 212562 87752 36843 SALLY STEPHENS CHIEF BUSINESS OFFICER 321210 3146 101206 991 4904 48 115699 1133 7927 78 550946 5396 101206 991 MARK BUSCH VP, QUALITY ASSURANCE 184181 82439 50162 22453 5232 2342 58777 26309 10540 4718 308892 138261 50162 22453 ROBERT STARR EXECUTIVE DIRECTOR, CLINICAL OPS & M 152744 77292 34475 17445 4131 2090 42865 21691 11652 5896 245867 124414 34475 17445 ROBERT DECKMAN VP, PRODUCT DEVELOPMENT 223508 8155 51400 1875 1434 52 74183 2707 44722 1632 395247 14421 51400 1875 SUSAN MARTIN VP, US COMMERCIAL BUSINESS 229247 0 53100 0 1873 0 64439 0 31879 0 380538 0 53100 0 AUTUMN EHNOW VP, PUBLIC POLICY & GOVERNMENT AFFAI 179911 0 66450 0 869 0 59360 0 29872 0 336462 0 66450 0 PART I, LINE 1A MEDICINES360 MADE GROSS-UP PAYMENTS FOR AIRLINE AWARDS STATUS FOR CERTAIN EXECUTIVE-LEVEL EMPLOYEES. PART I, LINE 1B MEDICINES360 DOES NOT HAVE A WRITTEN POLICY FOR GROSS-UP PAYMENTS. PART I, LINE 7 EMPLOYEES OF MEDICINES360 RECEIVED DISCRETIONARY BONUSES THAT WERE DETERMINED AND APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B BEFORE FILING, THE TAX RETURN IS PROVIDED TO THE BOARD AUDIT COMMITTEE FOR THEIR REVIEW AND APPROVAL, AND THE FULL BOARD FOR THEIR REVIEW. FORM 990, PART VI, SECTION B, LINE 12C OFFICERS/DIRECTORS ARE REQUIRED TO DISCLOSE OR UPDATE ANNUALLY INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE CEO COMPENSATION IS SET ON THE BASIS OF SALARY RANGES FOR COMPARABLY SIZED COMPANIES IN THE RADFORD GLOBAL LIFE SCIENCES SURVEY DATA AND COMPARABLE NON-PROFITS. THE COMPENSATION OF OFFICERS AND KEY EMPLOYEES ARE BENCH-MARKED AGAINST THE RADFORD GLOBAL LIFE SCIENCES SURVEY DATA AND COMPARABLE NON-PROFITS. THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE DATA AND COMPENSATION FOR THE CEO. THE COMPENSATION OF OFFICERS IS REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE, WHICH IS COMPRISED OF INDEPENDENT BOARD MEMBERS. FORM 990, PART VI, SECTION C, LINE 19 DOCUMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTANTS AND OUTSIDE SERVICES: PROGRAM SERVICE EXPENSES 1,945,179. MANAGEMENT AND GENERAL EXPENSES 535,072. FUNDRAISING EXPENSES 10,018. TOTAL EXPENSES 2,490,269. INTERCOMPANY SERVICE FEES: PROGRAM SERVICE EXPENSES 2,664,326. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,664,326. CLINICAL TRIAL SUPPORT: PROGRAM SERVICE EXPENSES 1,668,048. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,668,048. ENGINEERING SUPPORT: PROGRAM SERVICE EXPENSES 669,388. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 669,388. FORM 990, PART XI, LINE 9: RETURN OF UNSPENT PRIOR YEAR GRANT FUNDS -620,725. IMPACT RH360 LLC 353 SACRAMENTO STREET SUITE 300 SAN FRANCISCO CA 94111 MEDICAL PRODUCT DISTRIBUTION CA 0 89089 MEDICINES360 ALLIANCE PARTNERS360 INC 353 SACRAMENTO STREET SUITE 300 SAN FRANCISCO CA 94111 460978720 CLINICAL TRIAL SERVICES CA MEDICINES360 C 6664405 4481290 1.00000 1 0 0 0 0 1 0 0 0 0 0 0 0 1 1 1 0 1 0 0 ALLIANCE PARTNERS360 INC E 36082 ACTUAL ALLIANCE PARTNERS360 INC Q 3962940 ACTUAL ALLIANCE PARTNERS360 INC M 2664326 ACTUAL ALLIANCE PARTNERS360 INC N 106673 ACTUAL ALLIANCE PARTNERS360 INC O 1118970 ACTUAL